Let’s get into this week’s cup of biotech tea. ☕ If you only have time for one this week, I’d start with #2!
HHS allows compounding of 6 wellness peptides with ‘enforcement discretion’ ➡️
A Japanese biotech tackles tooth regeneration in an upcoming Phase 2 trial ➡️
Roche expands its automated IHC platform to detect mesothelioma ➡️
FDA initiates a new Alzheimer’s Prevention Accelerator ➡️
The U.S. midterms resulted in a wave of new STEM elected officials! ➡️
Biotech Term of the Week: intrathecal delivery ➡️
You’re not seeing today’s full issue because this is a paid-subscriber week. Upgrade to get every issue, every week.
New here? Catch up on last week’s free issue — there is plenty worth reading. See you next week!
Melanoma meets mRNA, longer-lasting masks, & Holmes up close
Let’s get into this week’s cup of biotech tea. ☕ If you only have time for one this week, I’d start with #1!
